Elder Pharma appoints Deloitte to restructure biz, brands

摘要

ELDER Pharmaceuticals has appointed consulting firm Deloitte for restructuring the company and its brands, including 'Eldervit', following the sale of its formulation business to Torrent Pharmaceuticals for Rs 2,004 crore. The company's overall strategy is to focus on its remaining brands, including Eldervit and Somazina, and position itself further in the growing nutraceuticals segment by launching more products, Elder Pharma said in a statement today.